Catalina Lopez Manzano

7PUBLICATIONS
48CO-AUTHORS
Regenerative medicine (incl. stem cells)BiomechanicsMolecular targetsDisease surveillanceCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 11, 2026
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.

|Jun 10, 2026
Defining Activity-Based Subgroups in Multiple Sclerosis: A Review and Framework Proposal.

|Jun 05, 2026
Treatments for metastatic non-small cell lung cancer: a pathways pilot with systematic review, evidence synthesis and economic model.

|Nov 12, 2025
Clinical and cost-effectiveness of technologies for the assessment of attention deficit hyperactivity disorder: a systematic review and economic model.

Eve Tomlinson, Mary Ward, Josephine Walker

|Oct 03, 2024
Plasma Ghrelin and Risks of Sex-Specific, Site-Specific, and Early-Onset Colorectal Cancer: A Mendelian Randomization Analysis.

Emma Hazelwood, Catalina Lopez Manzano, Emma E Vincent

|Sep 13, 2024
Clinical and cost-effectiveness of clopidogrel resistance genotype testing after ischaemic stroke or transient ischaemic attack: a systematic review and economic model.

Joe Carroll, Catalina Lopez Manzano, Eve Tomlinson

Pageof 2

Frequent Collaborators

7 joint publications

Penny Whiting

5 joint publications

Eve Tomlinson

5 joint publications

Chris Cooper

4 joint publications

Ayman Sadek